NEXGENRX INC. ("NexgenRx" or the "Corporation") (TSX VENTURE:NXG) is pleased to
report financial results for its third quarter, ended September 30, 2012.


Revenue for the quarter increased by 10.2% compared to the same period last
year, resulting in an 11.5% increase in gross profit. Other expenses of $822,934
were lower by 7% due to savings from the IT infrastructure project implemented
in June of last year in addition to improved debt and equity management.


"I am pleased to present the Q3 results which conti nue to demonstrate steady
revenue growth and improvements in expense management. The company recorded
positive net quarterly income of $150,952 compared with a loss of $161,947 for
the same period last year." stated Ron Loucks, President and CEO.


About NexgenRx

NexgenRx is a growing health benefits management company engaged in the design,
management and administration of health benefit plans offered by employers and
other plan sponsors for the benefit of their employees and plan members. More
information on NexgenRx can be found at www.nexgenrx.com.


Caution Regarding Forward-Looking Statements - This news release contains
certain forward looking statements, including statements regarding the business
and anticipated financial performance of the Corporation. These statements are
subject to a number of risks and uncertainties. Actual results may differ
materially from results contemplated by the forward-looking statements. When
relying on forward-looking statements to make decisions, investors and others
should carefully consider the foregoing factors and other uncertainties and
should not place undue reliance on such forward-looking statements.


FOR FURTHER INFORMATION PLEASE CONTACT: 
NexgenRx Inc.
Ronald C. Loucks
President and CEO
416.695.3393 x801


NexgenRx Inc.
Taba Merrikh
Director of Finance
416-695-3393x803

Nexgenrx (TSXV:NXG)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Nexgenrx Charts.
Nexgenrx (TSXV:NXG)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Nexgenrx Charts.